No cardiac sequelae after COVID-19: results of the one year follow-up with echocardiography and biomarkers

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F22%3A00127763" target="_blank" >RIV/00216224:14110/22:00127763 - isvavai.cz</a>
Result on the web
<a href="https://academic.oup.com/eurheartj/article/43/Supplement_2/ehac544.1540/6745361" target="_blank" >https://academic.oup.com/eurheartj/article/43/Supplement_2/ehac544.1540/6745361</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1093/eurheartj/ehac544.1540" target="_blank" >10.1093/eurheartj/ehac544.1540</a>

Result language
angličtina
Original language name
No cardiac sequelae after COVID-19: results of the one year follow-up with echocardiography and biomarkers
Original language description
Abstract Objective To evaluate the need for cardiac monitoring of unselected patients recovered from COVID-19 and to estimate the risk of heart failure development after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Methods During March 2020 and January 2021, 106 patients recovered from SARS-CoV-2 (alfa and beta variants) were enrolled in the prospective observational cohort study, CoSuBr (Covid Survivals in Brno). The diagnosis was established by reverse transcription polymerase chain reaction on swab test of the upper respiratory tract. Demographic parameters, patient history, clinical evaluation, cardiac biomarkers, ECG and echocardiography were recorded within three visits (V1 at least six weeks after infection, V2 three months later and V3 one year after V1).
Czech name
—
Czech description
—

Project
<a href="/en/project/LX22NPO5107" target="_blank" >LX22NPO5107: National institute for Neurological Research</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Publication year
2022
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)